Quest Diagnostics
DGX
#1030
Rank
โ‚น2.053 T
Marketcap
โ‚น18,464
Share price
-1.33%
Change (1 day)
28.78%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2025 (TTM): โ‚น775.58

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น837.67. In 2024 the company made an earnings per share (EPS) of โ‚น734.73 an increase over its 2023 EPS that were of โ‚น716.78.

EPS history for Quest Diagnostics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น775.585.56%
2024โ‚น734.732.5%
2023โ‚น716.78-5.83%
2022โ‚น761.17-49.21%
2021โ‚น1,49949.72%
2020โ‚น1,00166.67%
2019โ‚น600.6318%
2018โ‚น509.02-4.26%
2017โ‚น531.6923.19%
2016โ‚น431.58-7.11%
2015โ‚น464.6328.46%
2014โ‚น361.70-31.61%
2013โ‚น528.8560.46%
2012โ‚น329.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น994.43 18.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น67.22-108.02%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น83.11-109.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น194.55-76.77%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น19.83-102.37%๐Ÿ‡บ๐Ÿ‡ธ USA